A rational basis for selection among drugs of the same class

Heart. 2003 Jun;89(6):687-94. doi: 10.1136/heart.89.6.687.

Author

Morris J Brown¹

Affiliation

¹ Clinical Pharmacology Unit, Level 6, ACCI, Addenbrookes Hospital, Box 110, Cambridge CB2 2QQ, UK. m.j.brown@cai.cam.ac.uk

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Agonists / pharmacology
Adrenergic beta-Agonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Cardiovascular Agents / economics
Cardiovascular Agents / pharmacology
Cardiovascular Agents / therapeutic use*
Decision Making*
Drug Costs
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use

Substances

Adrenergic beta-Agonists
Angiotensin-Converting Enzyme Inhibitors
Cardiovascular Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors